Anti-interferon-.alpha. antibodies
CA 2437161 C · Owner: Kim, Jin K. · Inventors: Stewart, Timothy; Kim, Jin K.; Presta, Leonard G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to the generation and characterization of neutralizing anti-IFN-.alpha. monoclonal antibodies with broad reactivity against various IFN-.alpha. subtypes. The invention further relates to the use of such anti-IFN-.alpha. antibodies in the diagnosis and treatment of disorders associated with increased expression of IFN-.alpha. in particular autoimmune disorders such as insulin-dependent diabetes mellitus (IDDM) and systemic lupus erythematosus (SLE).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 29, 2002 and granted June 7, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 29, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 29, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.